• Most Popular
  • Most Shared

Sepracor says seeking drug development partner

Tue Oct 28, 2008 9:59am EDT

BOSTON, Oct. 28 (Reuters) - Sepracor Inc SEPR.O said on Tuesday that it is seeking a partner, preferably one that is outside the United States, to help develop some of its experimental drugs.

Stocks  |  Mergers & Acquisitions  |  Global Markets

Sepracor executives said on a conference call with investors that it is also looking to acquire or license new products from others.

"We continue to assess the potential for opportunistic M&A opportunities to give us the opportunity to leverage the organization," said Adrian Adams, the company's chief executive officer.

Sepracor, which makes the insomnia drug Lunesta, saw its shares rise 2.4 percent in early trading to $11.75 on Nasdaq. (Reporting by Toni Clarke, editing by Gerald E. McCormick)



More from Reuters

Photo

U.S. probing if al Qaeda linked to airplane incident

WASHINGTON (Reuters) - The United States is investigating whether al Qaeda was involved in a Christmas Day attempt to blow up a passenger jet, but there is no early evidence the Nigerian suspect in the case was part of a larger plot, the U.S. homeland security chief said on Sunday. | Video

A Delta Airbus 330 airliner sits on a runway at Detroit Metropolitan Airport in Romulus, Michigan in this video grab made December 25, 2009. Credit: REUTERS/WDIV TV/Handout

The battle in mid-air

The attraction of bombing airliners means the aviation industry has to be constantly vigilant in its fight against attackers.  Full Article 

A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
Political Risk in 2010:

Don't say we didn't warn you

With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article